Detalles de la búsqueda
1.
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.
J Endocrinol Invest
; 47(2): 433-442, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592052
2.
Changes in body composition in early breast cancer patients treated with aromatase inhibitors.
J Endocrinol Invest
; 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38856966
3.
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.
J Endocrinol Invest
; 47(3): 759, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37814065
4.
Working tables on Hormone Receptor positive (HR+), Human Epidermal growth factor Receptor 2 negative (HER2-) early stage breast cancer: Defining high risk of recurrence.
Crit Rev Oncol Hematol
; 191: 104104, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37659765
5.
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors' efficacy: a systematic review and meta-analysis of randomized studies.
ESMO Open
; 8(2): 100787, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36842300
6.
The Burden Associated with Non-Adherence in European Patients with Depression.
Value Health
; 17(7): A329, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27200562
7.
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis.
Lung Cancer
; 34 Suppl 4: S15-20, 2001 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-11742697
8.
Correlations between family history and cancer characteristics in 2256 breast cancer patients.
Br J Cancer
; 91(1): 96-8, 2004 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-15162141
9.
Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers.
Ann Oncol
; 11(5): 581-6, 2000 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-10907952
Resultados
1 -
9
de 9
1
Próxima >
>>